Tight control is important in patients with rheumatoid arthritis treated with an anti-tumor necrosis factor biological agent: prospective study of 91 cases who used a biological agent for more than 1

✍ Scribed by Hiroshige Sano; Katsumitsu Arai; Takehiro Murai; Junichi Fujisawa; Naoki Kondo; Takahiro Netsu; Tadamasa Hanyu; Takako Saeki; Tomoyuki Ito; Naoto Endo

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 181 KB
• Volume: 19
• Category: Article
• ISSN: 1439-7595
• DOI: 10.1007/s10165-009-0177-x